INTERCEPT PHARMACEUTICALS IN - NOTE 3.500% 2/1

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Debt / NOTE 3.500% 2/1
Total 13F principal
$0
Principal change
-$111,143,000
Total reported market value
$0
Number of holders
0
Value change
-$118,876,480
Number of sells
6

There are no holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.500% 2/1 as of Q4 2023.